Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04260659Phase 4Completed
Phase 4, randomised, open-label trial of dexmedetomidine, Lidocaine Hydrochloride Injection, without epinephrine, ketamine and magnesium sulfate in postoperative pain (2 arms), sponsored by Medical University of Warsaw. Primary endpoints: Total postoperative oxycodone consumption at Day 0 and Postoperative pain score in NRS scale at 24 hours. Started Feb 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04260659.